The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

Increasingly, telehealth platforms are positioning blockbuster weight-loss shots not as medicines to treat obesity or diabetes but as cosmetic elixirs for anyone who wants to lose a few pounds.

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ...

WeightWatchers plans to offer Novo Nordisk's Wegovy as a pill in the U.S. next year, enhancing their partnership. This move could boost WeightWatchers post-bankruptcy and align with its strategy to ...

The Memphis Grizzlies have had their struggles on the court this season. They are 4-9 on the year, and have just one win in their last eight games. Their latest loss against the Boston Celtics put ...

Boston Celtics center Neemias Queta (88) and guard Jordan Walsh (27) block a shot by Memphis Grizzlies forward Jaren Jackson Jr. on Wednesday, Nov. 12, 2025, in Boston. (Charles Krupa/AP) The Celtics ...

Oral weight-loss pills will be replacing GLP-1 shots by March 2026, Medicare and Medicaid Services Administrator Dr. Mehmet Oz predicted on Monday. Oz made the statement during a Monday morning ...

President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk. Sorry to spoil the celebration, but market competition probably would achieve the ...